Triple

T20340366
Position Surface form Disambiguated ID Type / Status
Subject Smith, Kline & French E495721 entity
Predicate notableProduct P1448 FINISHED
Object Thorazine NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Thorazine | Statement: [Smith, Kline & French, notableProduct, Thorazine]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Thorazine
Context triple: [Smith, Kline & French, notableProduct, Thorazine]
  • A. thioridazine
    Thioridazine is an older antipsychotic medication from the phenothiazine class, primarily used in the past to treat schizophrenia but now rarely prescribed due to its risk of serious heart rhythm disturbances.
  • B. Artane
    Artane is a residential suburb on Dublin’s Northside, known for its local shopping centre, schools, and proximity to the city centre.
  • C. Risperdal
    Risperdal is the brand name for risperidone, an atypical antipsychotic medication commonly prescribed to treat schizophrenia, bipolar disorder, and irritability associated with autism.
  • D. Serax
    Serax is a Belgian design brand known for its contemporary homeware, tableware, and decorative objects created in collaboration with renowned designers.
  • E. Toclafane
    The Toclafane are a race of deadly, cybernetic spheres revealed to be the future remnants of humanity in the Doctor Who universe, serving as instruments of mass destruction under the Master.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Thorazine
Target entity description: Thorazine is the brand name for chlorpromazine, a pioneering antipsychotic medication widely used to treat schizophrenia and other psychiatric disorders.
  • A. thioridazine
    Thioridazine is an older antipsychotic medication from the phenothiazine class, primarily used in the past to treat schizophrenia but now rarely prescribed due to its risk of serious heart rhythm disturbances.
  • B. Artane
    Artane is a residential suburb on Dublin’s Northside, known for its local shopping centre, schools, and proximity to the city centre.
  • C. Risperdal
    Risperdal is the brand name for risperidone, an atypical antipsychotic medication commonly prescribed to treat schizophrenia, bipolar disorder, and irritability associated with autism.
  • D. Serax
    Serax is a Belgian design brand known for its contemporary homeware, tableware, and decorative objects created in collaboration with renowned designers.
  • E. Toclafane
    The Toclafane are a race of deadly, cybernetic spheres revealed to be the future remnants of humanity in the Doctor Who universe, serving as instruments of mass destruction under the Master.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e0b4a1a09881908d97270d6971a25a completed April 16, 2026, 10:06 a.m.
NER Named-entity recognition batch_69e6783533a881909a12311bb9c66542 completed April 20, 2026, 7:02 p.m.
Created at: April 16, 2026, 11:23 a.m.